Treace Medical Concepts Quote - TMCI

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

8.36

Bid

8.00

Offer

8.55

Volume

107

0.00 Day's Range 0.00

3.92 52 Week Range 15.98

Market Cap

520.804M

Previous Close

8.36

Open

Last Trade

8.01

Last Trade Time

00:03:44

Financial Volume

VWAP

Average Volume (3m)

496,712

Shares Outstanding

62,297,078

Dividend Yield

PE Ratio

-10.52

Earnings Per Share (EPS)

-0.8

Revenue

187.12M

Net Profit

-49.53M

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of ... Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.treace.com

Headquarters

Wilmington, Delaware, USA

Founded

Treace Medical Concepts Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker TMCI. The last closing price for Treace Medical Concepts was US$8.36. Over the last year, Treace Medical Concepts shares have traded in a share price range of US$ 3.92 to US$ 15.98.

Treace Medical Concepts currently has 62,297,078 shares in issue. The market capitalisation of Treace Medical Concepts is US$520.80 million. Treace Medical Concepts has a price to earnings ratio (PE ratio) of -10.52.

Overall Flow

Bullish

Net Premium

25k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Form 8-K - Current report

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue

PONTE VEDRA, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Treace to Present at 43rd Annual J.P. Morgan Healthcare Conference

PONTE VEDRA, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure

PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant

PONTE VEDRA, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

PONTE VEDRA, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Treace Appoints Guy Guglielmino as Chief Commercial Officer

PONTE VEDRA, Fla., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Treace Announces Participation at Stifel 2024 Healthcare Conference

PONTE VEDRA, Fla., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.56	7.17948717949	7.8	8.52	7.16	335891	7.84607156	CS
4	0.83	11.0225763612	7.53	8.52	6.69	273375	7.44501574	CS
12	3.01	56.261682243	5.35	8.83	4.54	496712	7.18404199	CS
26	0.16	1.9512195122	8.2	8.83	4.54	585123	6.62621646	CS
52	-4.15	-33.173461231	12.51	15.98	3.92	747399	7.20729551	CS
156	-11.83	-58.593363051	20.19	27.97	3.92	531052	12.47982975	CS
260	-16.14	-65.8775510204	24.5	37.17	3.92	482528	13.97268545	CS

TMCI - Frequently Asked Questions (FAQ)

What is the current Treace Medical Concepts share price?

The current share price of Treace Medical Concepts is US$ 8.36

How many Treace Medical Concepts shares are in issue?

Treace Medical Concepts has 62,297,078 shares in issue

What is the market cap of Treace Medical Concepts?

The market capitalisation of Treace Medical Concepts is USD 520.8M

What is the 1 year trading range for Treace Medical Concepts share price?

Treace Medical Concepts has traded in the range of US$ 3.92 to US$ 15.98 during the past year

What is the PE ratio of Treace Medical Concepts?

The price to earnings ratio of Treace Medical Concepts is -10.52

What is the cash to sales ratio of Treace Medical Concepts?

The cash to sales ratio of Treace Medical Concepts is 2.78

What is the reporting currency for Treace Medical Concepts?

Treace Medical Concepts reports financial results in USD

What is the latest annual turnover for Treace Medical Concepts?

The latest annual turnover of Treace Medical Concepts is USD 187.12M

What is the latest annual profit for Treace Medical Concepts?

The latest annual profit of Treace Medical Concepts is USD -49.53M

What is the registered address of Treace Medical Concepts?

The registered address for Treace Medical Concepts is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Treace Medical Concepts website address?

The website address for Treace Medical Concepts is www.treace.com

Which industry sector does Treace Medical Concepts operate in?

Treace Medical Concepts operates in the SURGICAL,MED INSTR,APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NMHINatures Miracle Holding Inc	US$ 2.85 (152.21%)	49.17M
HEESH and E Equipment Services Inc	US$ 90.80 (106.65%)	790.87k
AIFFFirefly Neuroscience Inc	US$ 3.58 (88.42%)	28.26M
QETAQuetta Acquisition Corporation	US$ 16.77 (58.96%)	7
CFSBCFSB Bancorp Inc	US$ 10.82 (58.88%)	24
PHIOPhio Pharmaceuticals Corporation	US$ 3.76 (-43.03%)	2.91M
NESRNational Energy Services Reunited Corporation	US$ 5.01 (-41.95%)	1
CCECCapital Clean Energy Carriers Corporation	US$ 11.01 (-40.15%)	15
BSBKBogota Financial Corporation	US$ 5.11 (-34.91%)	3
MBIOMustang Bio Inc	US$ 0.15 (-33.01%)	2.2M
PIIIP3 Partners Inc	US$ 0.2733 (27.18%)	51.59M
NMHINatures Miracle Holding Inc	US$ 2.85 (152.21%)	49.17M
AIFFFirefly Neuroscience Inc	US$ 3.58 (88.42%)	28.26M
LAESSEALSQ Corporation	US$ 3.3988 (1.46%)	26.54M
GCTKGlucoTrack Inc	US$ 0.128 (-14.50%)	21.49M